SenesTech, Inc.
Close on Oct 19, 2026
- Market cap
- $3.71M
- P/E (TTM)
- –
- Dividend yield
- –
About SenesTech
Agricultural Chemicals, SIC 2870
SenesTech, Inc. develops and commercializes non-lethal pest management products that control rodent populations through fertility reduction. Its primary commercial offerings include Evolve, a soft bait line utilizing cottonseed oil that features Evolve Rat and Evolve Mouse, and ContraPest, a liquid bait formulation targeting male and female rat reproductive systems. The company serves clients across multiple distribution channels and target verticals, including agribusiness, professional pest management, industrial facilities, retail, and e-commerce markets.
The company operates internal production-scale capabilities at its manufacturing site and corporate headquarters in Surprise, Arizona. Its commercial footprint spans the United States, where ContraPest is registered across all 50 states, the District of Columbia, and two territories, while Evolve Rat and Evolve Mouse hold authorization in 48 and 37 states and territories, respectively. The firm also markets its products internationally through third-party distributors.
Summary of the business section of SenesTech's latest annual report, written by StockData.
Company profile
Company
- Legal name
- SenesTech, Inc.
- Founded
- 2004
- Headquarters
- Phoenix, AZ
- Address
- 777 W. Pinnacle Peak Road, Suite B104 85027
- Phone
- (928) 779-4143
- Employees
- 23, Dec 31, 2025
- Industry
- Agricultural Chemicals
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- M&K CPAS, PLLC, The Woodlands, TX
Stock & identifiers
- Ticker
- SNES
- Exchange
- Nasdaq
- IPO date
- Dec 8, 2016
- Shares outstanding
- 5M, Aug 4, 2026
- Public float
- $19.16M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-10 reverse, Jul 25, 2024; 1-for-9.5 reverse, Feb 21, 2024; 1-for-12 reverse, Nov 17, 2023; 1-for-20 reverse, Dec 31, 2022; 1-for-20 reverse, Nov 16, 2022; 1-for-20 reverse, Mar 17, 2020; 1-for-20 reverse, Feb 5, 2020
- SEC CIK
- 1680378
- CUSIP
- 81720R604
- ISIN
- US81720R6045
- LEI
- 549300YVNQPK8VJ8TT73
- EIN
- 20-2079805
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Michael Edell | Chief Executive Officer, Director | 11,000 |
| Thomas C. Chesterman | CFO & Treasurer | 9,876 |
| Jamie Bechtel Morrison | Director | 2,812 |
| Matthew K. Szot | Director | 4,658 |
| Jacob Steven Leach | Director | 0 |
| Lynn Yako Graham | Director | 0 |
| Phillip Nicholas Grandinetti III | Director | – |
| Joshua Matthew Moss | Director | 0 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Mr Fruendt | $360.04K | $280.32K | $245.15K | $1 | – |
| FY2024 Mr Fruendt | $565.07K | $570.15K | $373.55K | $1 | – |
| FY2024 Mr Siegel | $0 | $0 | $373.55K | $1 | – |
| FY2023 Mr Fruendt | $343.04K | $340.00K | $222.73K | $3 | – |
| FY2023 Mr Siegel | $0 | $0 | $222.73K | $3 | – |
| FY2022 Mr Fruendt | $239.29K | $264.06K | $340.93K | $15 | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had 23 full-time employees and one part-time employee.”
Corporate history
Events identified from SEC filings